The Quiet Exit From Independent Practice
Anesthesiology has long been one of the more insulated corners of medicine – a specialty where independent group practice held on longer than most. Surgeons needed anesthesiologists, hospitals needed coverage, and the economics of running a tight regional group were defensible enough that selling to a larger entity felt optional rather than necessary. That calculation is changing, and changing fast.
Across the country, regional anesthesiology groups that have operated independently for decades are signing letters of intent with national physician management companies. The deals are often quiet, announced internally before any public disclosure, and structured in ways that keep the original group’s branding intact while shifting ownership, billing, and contract leverage to a national platform.
The reasons are rarely simple.
Why Groups Are Selling Now
The economics of anesthesiology have grown increasingly hostile to independent practice over the past several years. Hospital systems have consolidated their surgical volumes, which gives them stronger negotiating leverage over anesthesia contracts. A regional group covering two or three hospitals can find itself renegotiating rates under dramatically different conditions than it faced a decade ago – often with a health system that now owns competing facilities and has its own preferred vendor relationships. Independent groups that once held exclusive contracts are discovering those contracts aren’t being renewed on the same terms, if at all.
Staffing is the other pressure point. Certified Registered Nurse Anesthetists have become central to how anesthesia coverage gets delivered, and recruiting them in a competitive market requires compensation packages and scheduling flexibility that smaller groups struggle to offer. A national platform with hundreds of CRNAs across multiple states can provide coverage depth, cross-credentialing, and recruitment pipelines that a 20-person regional group simply cannot build alone. When a regional group loses a key anesthesiologist mid-contract or faces a gap in overnight coverage, the vulnerability is immediate and visible to the hospital client. National operators sell stability as much as they sell anything else.
Reimbursement complexity adds to the strain. Anesthesia billing operates on a unit-based system tied to base units, time units, and qualifying circumstances – a structure that requires specialized coding expertise and constant attention to payer policy changes. Medicare and commercial payer audits have become more frequent, and the administrative burden of staying compliant has grown significantly. Groups that built their billing operations in-house are now looking at what it would cost to modernize those systems and concluding that the capital requirement alone makes acquisition look rational.
Who Is Buying and What They Want
The buyers in this space are largely private equity-backed physician management organizations that have spent the past decade assembling national anesthesia networks. These platforms operate across dozens of states, hold contracts with major health systems, and have the scale to absorb regional groups without disrupting ongoing coverage. The acquisition model is familiar: buy the group, retain the physicians under employment or professional services agreements, centralize billing and compliance, and use the expanded footprint to renegotiate contracts with hospital clients from a stronger position.
What national platforms gain from regional acquisitions is geographic density. Covering an underserved region, filling a gap between two existing markets, or locking in a hospital relationship before a competitor can – these are the strategic drivers behind individual deals. A regional group with a 15-year relationship with a community hospital system is worth considerably more than its current revenue run rate suggests, because that relationship transfers with the acquisition and represents a barrier to entry for any competitor trying to enter that market.
This pattern is visible across other specialty areas. Regional diagnostic imaging centers have gone through a similar consolidation wave, with independent operators finding that national radiology platforms offered both capital and contract security that standalone operations couldn’t replicate. Anesthesiology is following a comparable trajectory, with the added complexity that anesthesia coverage is operationally embedded in surgical workflows in ways that make switching costs high for hospitals – which makes the contracts more valuable and the acquisitions more aggressively pursued.
What Physicians Inside These Groups Actually Face
For the anesthesiologists themselves, the experience of a sale is rarely what the initial pitch suggests. Founders typically receive meaningful upfront compensation and are told that day-to-day practice won’t change. In many cases, the early months of an acquisition bear that out – clinical autonomy remains intact, scheduling looks familiar, and the new ownership is deliberately hands-off while integration happens quietly in the back office.
The changes that arrive later tend to be structural. Compensation models shift from profit-sharing arrangements, where physicians benefit directly from group efficiency, to salary-based or RVU-driven structures that decouple individual income from group performance. Credentialing decisions, coverage dispute resolutions, and contract negotiations with hospitals all move to a centralized corporate function. Physicians who were accustomed to having a vote on strategic decisions find themselves several layers removed from those conversations. This isn’t unique to anesthesiology – it mirrors the experience reported by physicians across specialties who have sold to private equity-backed platforms – but in a specialty built on precision and accountability, the cultural distance can be jarring.
Younger anesthesiologists joining a group post-acquisition often have no frame of reference for independent practice and may experience the employment structure as simply how anesthesiology works. The loss of institutional knowledge about what independent group practice looks like – and what it offers – happens gradually, one cohort at a time.
Where This Leaves the Market
The window for independent anesthesiology groups to negotiate from a position of genuine strength is narrowing, not because national networks have won the market outright, but because the number of viable independent alternatives is shrinking with each completed deal – and hospitals that might have preferred a local group increasingly find that the local group no longer exists as an independent entity.
